EIRION THERAPEUTICS
Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products for aesthetic dermatology. The company currently has a rich pipeline of products focusing on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. In the future, Eirion plans to also pursue additional indications that address other major unmet clinical needs for physicians and their patients.
EIRION THERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Woburn, Massachusetts, United States
Country:
United States
Website Url:
http://www.eirionthera.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Register.com DNS Network Solutions Sun ONE Web Server Sun ONE Web Server V6.1
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Gore Range Capital
Gore Range Capital investment in Series A - Eirion Therapeutics
Haohai Biological Technology
Haohai Biological Technology investment in Series A - Eirion Therapeutics
Kinled Holding
Kinled Holding investment in Series A - Eirion Therapeutics
Official Site Inspections
http://www.eirionthera.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Eirion Therapeutics"
HOME | Eirion
Aesthetic Medicine and. Medical Dermatology Innovation. Copyright 2025 Eirion Therapeutics, Inc. All rights reserved. bottom of pageSee details»
OUR TEAM - Eirion
Jon Edelson, MD. Chairman, CEO & President Mary Senica, MS. Executive Vice President, Quality Assurance and Compliance . Michael Eppolito, MBA. Senior Vice President, Research …See details»
Eirion Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription …See details»
CONTACT - Eirion
Eirion Therapeutics . 25-K Olympia Avenue | Suite 200 . Woburn, MA 01801 Email: [email protected]See details»
Eirion Therapeutics - LinkedIn
Eirion Therapeutics | 160 followers on LinkedIn. Eirion is developing innovative prescription products for aesthetic medicine and medical dermatology.See details»
Eirion 2025 Company Profile: Valuation, Funding & Investors
Eirion General Information Description. Developer of prescription products intended for aesthetic dermatology. The company's products focus on the treatment of wrinkles, primary axillary …See details»
Eirion Therapeutics - VentureRadar
Website: http://www.eirionthera.com/ Eirion Therapeutics, Inc. is a privately held, clinical stage biopharmaceutical company that is developing next-generation ...See details»
Eirion Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Explore Eirion Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 3 news, and 1 literature, Technology Platform ...See details»
Eirion Therapeutics, Inc. (Eirion Therapeutics, Inc.) - 药物管线_专 …
Demonstrates Potential for ET-02 to be Significantly More Effective Than Existing Treatments for Hair Loss WOBURN, Mass., Jan. 8, 2025 /PRNewswire/ -- Eirion Therapeutics Inc., a …See details»
Eirion Therapeutics Company Profile | Management and
[email protected]: Eirion Therapeutics Top Competitors. Company Employees Revenue Top technologies; Barbara K Honig, Md. 9: $1.6 M: Verdugo Dermatology. 13: $1.8 M: L …See details»
Eirion Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Eirion Therapeutics - Craft
Eirion Therapeutics is a clinical-stage biopharmaceutical company developing prescription products for aesthetic dermatology. It mainly focuses on treatments for wrinkles, primary …See details»
Jon Edelson, MD - Eirion
Jon Edelson, MD. Chairman, CEO & President Jon Edelson, MD, has been our Chairman, CEO & President since our inception in January 2016. Dr.See details»
Eirion Therapeutics - Overview, News & Similar companies
Jan 25, 2023 www.eirionthera.com. Revenue <$5 Million. Industry Hospitals & Clinics Healthcare . Recent News & Media. Eirion Therapeutics to Present at the 2024 IMCAS WORLD …See details»
Eirion Therapeutics Announces Strategic Agreement for HTL …
To learn more about Eirion: www.eirionthera.com . 2 About HTL HTL is a leading biotech and industrial player in the development and production of innovative, pharmaceutical-grade …See details»
Eirion Therapeutics, Inc. Closes $40 Million Series A Investment …
WOBURN, Mass., March 9, 2021 /PRNewswire/ -- Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with …See details»
Eirion Therapeutics, Inc. Closes $40 Million Series A ... - Stem Cell
WOBURN, Mass., March 9, 2021 /PRNewswire/ --Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with …See details»
Eirion Therapeutics-动脉网
Eirion Therapeutics, Inc.是一家私人控股的临床阶段生物制药公司，正在开发下一代皮肤美容处方产品。Eirion目前拥有丰富的产品线，专注于皱纹、原发性腋毛多汗症、雄激素性脱发和头发 …See details»
PIPELINE - Eirion
Product Candidates . ET-01 Topical Botulinum for Lateral Canthal Lines (Crow’s Feet) and Primary Axillary Hyperhidrosis. ET-01 is a topical botulinum product being developed with the …See details»
Theratechnologies Receives FDA Approval for EGRIFTA WR™ …
New, improved formulation set to replace EGRIFTA SV ®. MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) …See details»